rs876657776
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_005219.5(DIAPH1):c.3637C>T(p.Arg1213Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000205 in 1,461,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
DIAPH1
NM_005219.5 stop_gained
NM_005219.5 stop_gained
Scores
3
3
1
Clinical Significance
Conservation
PhyloP100: 5.14
Genes affected
DIAPH1 (HGNC:2876): (diaphanous related formin 1) This gene is a homolog of the Drosophila diaphanous gene, and has been linked to autosomal dominant, fully penetrant, nonsyndromic sensorineural progressive low-frequency hearing loss. Actin polymerization involves proteins known to interact with diaphanous protein in Drosophila and mouse. It has therefore been speculated that this gene may have a role in the regulation of actin polymerization in hair cells of the inner ear. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0477 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-141524167-G-A is Pathogenic according to our data. Variant chr5-141524167-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 228577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-141524167-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIAPH1 | NM_005219.5 | c.3637C>T | p.Arg1213Ter | stop_gained | 27/28 | ENST00000389054.8 | NP_005210.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIAPH1 | ENST00000389054.8 | c.3637C>T | p.Arg1213Ter | stop_gained | 27/28 | 5 | NM_005219.5 | ENSP00000373706 | A2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461874Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727238
GnomAD4 exome
AF:
AC:
3
AN:
1461874
Hom.:
Cov.:
30
AF XY:
AC XY:
2
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 25, 2024 | Identified in multiple unrelated individuals with autosomal dominant sensorineural hearing loss in published literature; thrombocytopenia was also reported in several families (PMID: 28983057, 27911912, 26912466, 27808407, 27707755); Published functional studies demonstrate the p.(R1213X) variant causes increased activity as compared to wild-type (PMID: 26912466, 27707755); Nonsense variant predicted to result in protein truncation as the last 60 amino acids are lost; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 27808407, 37543941, 34232383, 27707755, 29985732, 27911912, 28815995, 31152317, 31473629, 32594080, 34223798, 28983057, 26912466) - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 19, 2018 | - - |
Autosomal dominant nonsyndromic hearing loss 1 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 25, 2019 | - - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 04, 2018 | The p.Arg1213X variant in DIAPH1 has been reported in six probands with either h earing loss or hearing loss with thrombocytopenia and segregated in 10 affected family members (Iwasa 2016, Stritt 2016, Ueyama 2016, Neuhaus 2017). This varian t was absent from large population studies. A mouse model expressing the p.Arg12 13X variant exhibited progressive hearing loss and loss of inner and outer hair cells. Homozygous mice exhibited an exacerbated hearing loss (Ueyama 2016). Addi tional studies performed in transfected cells indicate that this variant may res ult in constitutive activation of the DIAPH1 protein, a member of the formin pro tein family, which nucleate and elongate actin (Ueyama 2016). Furthermore, cultu red megakaryocytes from patients harboring p.Arg1213X showed reduced proplatelet formation, cell clustering and abnormal cortical filamentous actin, and platele ts had increased actin and stable microtubules. RT-PCR performed on samples from 2 probands showed presence of both wild-type and Arg1213X mRNA, suggesting that the DIAPH1 is prematurely truncated. Collectively, the functional evidence sugg ests either a gain-of-function or dominant negative effect. In summary, this var iant meets criteria to be classified as pathogenic for autosomal dominant hearin g loss with thrombocytopenia. ACMG/AMP criteria applied: PS3, PP1_Strong, PM2, P S4_Moderate. - |
Autosomal dominant nonsyndromic hearing loss 1;C5567650:Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 16, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this premature translational stop signal affects DIAPH1 function leading to constitutive activation for gain-of-function (PMID: 26912466, 27707755, 32678080). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 228577). This variant is also known as c.3610C>T (R1204X). This premature translational stop signal has been observed in individual(s) with autosomal dominant hearing loss with or without macrothrombocytopenia (PMID: 26912466, 27707755, 27808407, 27911912, 28815995, 28983057). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg1213*) in the DIAPH1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 60 amino acid(s) of the DIAPH1 protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
D;D;D;D;D;D;D;D
Vest4
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at